Skip to main content
. Author manuscript; available in PMC: 2012 Mar 1.
Published in final edited form as: Cancer Res. 2011 Jan 6;71(5):1526–1532. doi: 10.1158/0008-5472.CAN-10-3069

Figure 1. Design of EGF-SERS nanoparticle for labeling and detection of CTCs.

Figure 1

(A) Preparation and schematic structures of Raman-encoded, PEG-stabilized, and EGF-peptide–functionalized SERS nanoparticle. (B)TEM image and DLS measurement, (C) assay principle of CTC detection from whole blood using EGF-SERS nanoparticles.